• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[根据日本流行病学研究看出血性小肠结肠炎和溶血尿毒综合征抗生素治疗的新老问题]

[The old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies].

作者信息

Kohsaka T, Tagawa M, Suzuki T, Ito H

机构信息

National Children's Hospital, Renal Gastroenterology dept.

出版信息

Nihon Rinsho. 1997 Mar;55(3):706-14.

PMID:9086785
Abstract

The treatment for hemorrhagic enterocolitis due to O157 E. coli infection has been discussed to prevent its aggravation to HUS, especially in terms of the effect of antibiotics. In June, 1996, massive outbreak of the infection occurred in Sakai city, Osaka, Japan. For the purpose of the prevention against secondary infection, antibiotics therapy was employed routinely in Sakai. The epidemiological results were as follows. A total of 25996 school children probably faced infection. Among them 4671 (admission 995) children became symptomatic and 102 developed HUS, leading the ratio of HUS versus symptomatic children to 2.18% which is significantly less than the average occurrence ratio of 4.0% at the same age group nationwide. We studied the possibility of lowering the incidence of HUS by the early diagnosis and the use of antibiotics. According to our survey(86-95), we examined 193 diarrhea associated HUS cases on the effect of antibiotics. There is no meaningful change despite treatment of antibiotics during enterocolitis stage in reducing the complication of HUS, but antibiotics therapy after the onset of HUS brought the prolongation of disease course. These two results were controversial, but the main factor might be the age difference between the two study groups. As previously reported, we could'nt propose the administration of antibiotics to the infants with hemorrhagic enterocolitis due to E. coli O157.

摘要

为预防因O157大肠杆菌感染所致出血性小肠结肠炎恶化为溶血尿毒综合征(HUS),尤其是针对抗生素的作用,人们已对其治疗方法展开了讨论。1996年6月,日本大阪堺市发生了该感染的大规模暴发。为预防继发感染,堺市常规采用了抗生素治疗。流行病学结果如下:共有25996名学童可能面临感染。其中4671名(入院995名)儿童出现症状,102名发展为溶血尿毒综合征,溶血尿毒综合征患儿与有症状儿童的比例为2.18%,显著低于全国同年龄组4.0%的平均发病率。我们研究了通过早期诊断和使用抗生素降低溶血尿毒综合征发病率的可能性。根据我们的调查(86 - 95),我们检查了193例腹泻相关性溶血尿毒综合征病例使用抗生素的效果。在小肠结肠炎阶段使用抗生素治疗,在降低溶血尿毒综合征并发症方面并无显著变化,但在溶血尿毒综合征发病后使用抗生素治疗会导致病程延长。这两个结果存在争议,但主要因素可能是两个研究组之间的年龄差异。如先前报道,我们无法建议对因大肠杆菌O157所致出血性小肠结肠炎的婴儿使用抗生素。

相似文献

1
[The old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies].[根据日本流行病学研究看出血性小肠结肠炎和溶血尿毒综合征抗生素治疗的新老问题]
Nihon Rinsho. 1997 Mar;55(3):706-14.
2
[Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].[阪急疫情中大肠杆菌O157肠炎患者溶血尿毒综合征发病率与抗生素之间关系的回顾性分析]
Kansenshogaku Zasshi. 1998 Mar;72(3):266-72. doi: 10.11150/kansenshogakuzasshi1970.72.266.
3
Management of diarrhea-associated hemolytic uremic syndrome in children.儿童腹泻相关性溶血尿毒综合征的管理
Clin Exp Nephrol. 2008 Feb;12(1):16-9. doi: 10.1007/s10157-007-0007-4. Epub 2008 Jan 5.
4
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
5
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.1996年阪南市肠出血性大肠杆菌O157感染大规模爆发期间阪南市立医院的临床经验。
Pediatr Int. 1999 Apr;41(2):213-7. doi: 10.1046/j.1442-200x.1999.4121041.x.
6
Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.与溶血性尿毒症综合征相关的大肠杆菌O157:H7感染的危险因素。
Pediatr Int. 1999 Apr;41(2):218-22. doi: 10.1046/j.1442-200x.1999.4121040.x.
7
Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7.早期口服氟喹诺酮类药物对大肠杆菌O157:H7所致出血性结肠炎的影响。
Pediatr Int. 1999 Apr;41(2):228-32. doi: 10.1046/j.1442-200x.1999.4121038.x.
8
[The clinical course and laboratory data of hemorrhagic colitis caused by Escherichia coli O157:H7].[大肠杆菌O157:H7所致出血性结肠炎的临床病程及实验室数据]
Rinsho Byori. 1997 Sep;45(9):865-8.
9
The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome.产志贺毒素大肠杆菌在出血性结肠炎和溶血性尿毒综合征中的作用。
Semin Pediatr Infect Dis. 2004 Oct;15(4):260-5. doi: 10.1053/j.spid.2004.07.007.
10
Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996.肠出血性大肠杆菌O157:H7感染所致儿童溶血尿毒综合征的临床特征与治疗:1996年在堺市一次暴发的经验
Pediatr Int. 1999 Apr;41(2):223-7. doi: 10.1046/j.1442-200x.1999.4121039.x.

引用本文的文献

1
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染抗生素治疗后溶血尿毒综合征的风险。
N Engl J Med. 2000 Jun 29;342(26):1930-6. doi: 10.1056/NEJM200006293422601.